Diabetic Foot Ulcers Epidemiology Summary

• Diabetic Foot Ulcer is a chronic, non-healing wound that commonly occurs on the feet of patients with diabetes due to peripheral neuropathy, poor blood circulation, and impaired wound healing. Diabetic Foot Ulcers are associated with a high risk of infection, hospitalization, and lower-limb amputation.
• The major types of Diabetic Foot Ulcer include neuropathic ulcers, caused primarily by nerve damage and loss of protective sensation; ischemic ulcers, resulting from inadequate blood supply due to peripheral arterial disease; and neuroischemic ulcers, which involve both neuropathy and ischemia and are often more difficult to heal.
• Diabetic Foot Ulcer is more prevalent in Asian countries such as Japan due to the rising prevalence of diabetes mellitus, increasing aging population, high burden of peripheral neuropathy and peripheral arterial disease, and delayed wound recognition and treatment, which collectively contribute to higher rates of chronic non-healing ulcers and complications.
• Males face a higher lifetime risk of developing Diabetic Foot Ulcer and experience a greater disease burden compared to females. This disparity is largely attributed to higher prevalence of risk factors such as smoking, poorer glycemic control, increased rates of peripheral arterial disease and neuropathy, delayed health-seeking behavior, and lower adherence to preventive foot care practices.
• Increasing global prevalence of diabetes mellitus, population aging, rising obesity rates, sedentary lifestyles, and poor glycemic control are expected to sustain the global Diabetic Foot Ulcer burden over the next decade. Strengthening diabetes management programs, improving early identification of high-risk patients through routine foot screening, and expanding access to advanced wound care therapies and multidisciplinary foot care services will remain key determinants of future trends.

Diabetic Foot Ulcer Epidemiology Forecast in 7MM

• 2025 Prevalent Cases of Diabetic Foot Ulcer: ~ 6,600,000
• Diabetic Foot Ulcer Growth Rate (2026–2036): ~10% CAGR

DelveInsight's "Diabetic Foot Ulcer Epidemiology Forecast – 2036" report delivers an in-depth understanding of the Diabetic Foot Ulcer, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Diabetic Foot Ulcer Understanding and Diagnosis Algorithm

Diabetic Foot Ulcer Overview

Diabetic Foot Ulcer is a serious and common complication of diabetes, arising from a combination of peripheral neuropathy, peripheral arterial disease, and impaired wound healing. It occurs when minor trauma or pressure on the foot goes unnoticed due to loss of sensation, leading to skin breakdown and chronic ulcer formation. Diabetic Foot Ulcers can range from superficial wounds to deep ulcers involving muscle and bone, often accompanied by infection in advanced stages. Common symptoms include non-healing wounds, redness, swelling, discharge, and, in severe cases, tissue necrosis. Diabetic Foot Ulcer is primarily caused by prolonged hyperglycemia, poor circulation, and repetitive mechanical stress. Diagnosis is based on clinical examination, wound assessment, and vascular evaluation.

Diabetic Foot Ulcer Diagnosis

Diabetic Foot Ulcer is diagnosed through clinical examination and supportive tests, often detected during routine foot checks in diabetic patients. Physical assessment focuses on ulcer size, depth, infection signs, and evaluation of neuropathy and blood circulation. Blood tests such as glucose levels and HbA1c assess glycemic control, while imaging (X-ray or MRI) may be used to detect deep infection or osteomyelitis. Vascular tests like ankle-brachial index (ABI) help identify poor blood flow, and wound cultures may be performed to guide treatment in infected ulcers.

Further details are provided in the report...

Diabetic Foot Ulcer Epidemiology

Key Findings from Diabetic Foot Ulcer Epidemiological Analysis and Forecast

• According to DelveInsight’s estimates, the total prevalent cases of Diabetic Foot Ulcer in the 7MM were approximately 6,600, 000 in 2025.
• Among the EU4, Italy accounted for the highest number of prevalent cases of Diabetic Foot Ulcer, followed by Germany, whereas Spain accounted for the lowest number of cases in 2025.
• The observed male predominance and earlier onset of Diabetic Foot Ulcer highlight the importance of early risk stratification, routine foot screening, and targeted preventive care strategies in high-risk populations to reduce complications and improve outcomes.
• The prevalence of Diabetic Foot Ulcer was 77% in the US population. Females had a lower prevalence of Diabetic Foot Ulcer than males.

Scope of the Diabetic Foot Ulcer Epidemiology Report

• The report covers a segment of an executive summary, a descriptive overview of Diabetic Foot Ulcer, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Diabetic Foot Ulcer Epidemiology Report Insights

• Diabetic Foot Ulcer Patient Population Forecast

Diabetic Foot Ulcer Epidemiology Report Key Strengths

• Diabetic Foot Ulcer Epidemiology based (epi based) Bottom up Forecasting
• 11-year Forecast
• Diabetic Foot Ulcer Patient Burden Trends (by Geography)

FAQs

• What are the disease risks, burdens, and unmet needs of Diabetic Foot Ulcer? What will be the growth opportunities across the 7MM concerning the patient population with Diabetic Foot Ulcer?
• What is the historical and forecasted Diabetic Foot Ulcer patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy Diabetic Foot Ulcer Epidemiology Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.